APA

Krishna V. S., Zheng S., Rekha E. M., Nallangi R., Sai Prasad D. V., George S. E., Guddat L. W. & Sriram D. (20201130). Design and development of ((4-methoxyphenyl)carbamoyl) (5-(5-nitrothiophen-2-yl)-1,3,4-thiadiazol-2-yl)amide analogues as Mycobacterium tuberculosis ketol-acid reductoisomerase inhibitors. : European journal of medicinal chemistry.

Chicago

Krishna Vagolu Siva, Zheng Shan, Rekha Estharla Madhu, Nallangi Radhika, Sai Prasad D V, George Shilpa E, Guddat Luke W and Sriram Dharmarajan. 20201130. Design and development of ((4-methoxyphenyl)carbamoyl) (5-(5-nitrothiophen-2-yl)-1,3,4-thiadiazol-2-yl)amide analogues as Mycobacterium tuberculosis ketol-acid reductoisomerase inhibitors. : European journal of medicinal chemistry.

Harvard

Krishna V. S., Zheng S., Rekha E. M., Nallangi R., Sai Prasad D. V., George S. E., Guddat L. W. and Sriram D. (20201130). Design and development of ((4-methoxyphenyl)carbamoyl) (5-(5-nitrothiophen-2-yl)-1,3,4-thiadiazol-2-yl)amide analogues as Mycobacterium tuberculosis ketol-acid reductoisomerase inhibitors. : European journal of medicinal chemistry.

MLA

Krishna Vagolu Siva, Zheng Shan, Rekha Estharla Madhu, Nallangi Radhika, Sai Prasad D V, George Shilpa E, Guddat Luke W and Sriram Dharmarajan. Design and development of ((4-methoxyphenyl)carbamoyl) (5-(5-nitrothiophen-2-yl)-1,3,4-thiadiazol-2-yl)amide analogues as Mycobacterium tuberculosis ketol-acid reductoisomerase inhibitors. : European journal of medicinal chemistry. 20201130.